Log in

Relevant bibliographies by topics / Whole-Brain Radiotherapy / Journal articles

To see the other types of publications on this topic, follow the link: Whole-Brain Radiotherapy.

Journal articles on the topic 'Whole-Brain Radiotherapy'

Author: Grafiati

Published: 3 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Whole-Brain Radiotherapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Goodwin, Peter M. "Whole Brain Radiotherapy." Oncology Times 38, no. 19 (2016): 33. http://dx.doi.org/10.1097/01.cot.0000503434.94497.c6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

M.D (R.T), Dr C. S. K. Prakash. "High Grade Asrtocytomas Whole Brain Radiotherapy (WBRT) vs Limited Volume Brain Radiotherapy (LVBRT)- A Prospective Randomized Study." Journal of Medical Science And clinical Research 04, no. 10 (2016): 13197–208. http://dx.doi.org/10.18535/jmscr/v4i10.66.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Chinnaiyan, Prakash, Emory McTyre, and Jacob Scott. "Whole brain radiotherapy for brain metastasis." Surgical Neurology International 4, no. 5 (2013): 236. http://dx.doi.org/10.4103/2152-7806.111301.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Kaidar-Person, Orit, Carey K. Anders, and Timothy M. Zagar. "Whole Brain Radiotherapy for Brain Metastases." JAMA 316, no. 4 (2016): 393. http://dx.doi.org/10.1001/jama.2016.8692.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Dong, Weiwei, Yun Zhou, Xiangyang Jiang, and Yan Zhou. "Comparative Efficacy of Whole-Brain Radiotherapy Combined with Supplemental Precision Radiotherapy and Whole-Brain Radiotherapy Alone for Brain Metastases." Oncology Treatment Discovery 2, no. 1 (2024): 41–46. http://dx.doi.org/10.26689/otd.v2i1.6294.

Full text

Abstract:

Objective: To investigate the efficacy of whole-brain radiotherapy combined with supplemental precision radiotherapy compared to whole-brain radiotherapy alone for brain metastasis. Methods: Twenty-six cases of patients with brain metastasis were observed from January 2020 to June 2023. Thirteen cases each were randomly assigned to the observation group and the control group. The patients in the observation group received whole-brain radiotherapy combined with supplemental precision radiotherapy, while those in the control group received only whole-brain radiotherapy. Results: Comparing the qu

APA, Harvard, Vancouver, ISO, and other styles

6

Rades, Dirk, Susanne Kieckebusch, Tiina Haatanen, Radka Lohynska, Juergen Dunst, and Steven E. Schild. "Surgical Resection Followed by Whole Brain Radiotherapy Versus Whole Brain Radiotherapy Alone for Single Brain Metastasis." International Journal of Radiation Oncology*Biology*Physics 70, no. 5 (2008): 1319–24. http://dx.doi.org/10.1016/j.ijrobp.2007.08.009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Ho, Andrew, Farasat Kazmi, Hannah Hendry, and Pinelopi Gkogkou. "SURVIVAL OUTCOMES AFTER WHOLE BRAIN RADIOTHERAPY." Neuro-Oncology 25, Supplement_3 (2023): iii19—iii20. http://dx.doi.org/10.1093/neuonc/noad147.083.

Full text

Abstract:

Abstract AIMS Cerebral metastases from extra-cranial primary cancer carries a poor prognosis. For patients in whom surgical resection or SRS are not suitable, local control rates are poor. There is considerable debate surrounding the value of whole brain radiotherapy in this patient cohort in terms of local control, survival and functional status. We aimed to measure survival in patients receiving whole brain radiotherapy at the Norfolk and Norwich University Hospital. METHOD All patients who completed a course of whole brain radiotherapy at our centre between April 2018 and December 2022 were

APA, Harvard, Vancouver, ISO, and other styles

8

Chyrmang, Deiwakor, Yumkhaibam S. Devi, Kishalay Baidya, Laishram J. Singh, Daffilyne L. Nongrum, and Ningthoujam D. Devi. "A comparative study of whole brain radiotherapy with concomitant thalidomide versus whole brain radiotherapy alone in brain metastases." Journal of Cancer Research and Therapeutics 20, no. 1 (2023): 255–60. http://dx.doi.org/10.4103/jcrt.jcrt_1724_22.

Full text

Abstract:

Background: Brain metastasis increases morbidity and mortality in cancer patients. This study was undertaken to compare tumor response and treatment-related toxicities in patients treated with orally administered thalidomide concomitantly with whole brain radiotherapy to whole brain radiotherapy alone in brain metastases. Methods: This randomized control trial was conducted in radiation oncology department, RIMS among 42 patients of brain metastases distributed in two study arms during the period August 2018 to July 2020. Twenty patients in Arm-A received whole brain radiotherapy to a dose of

APA, Harvard, Vancouver, ISO, and other styles

9

Oskan, F., U. Ganswindt, S. B. Schwarz, F. Manapov, C. Belka, and M. Niyazi. "Hippocampus sparing in whole-brain radiotherapy." Strahlentherapie und Onkologie 190, no. 4 (2014): 337–41. http://dx.doi.org/10.1007/s00066-013-0518-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Giubilei, Cesare, Gianluca Ingrosso, Marco D’Andrea, Michaela Benassi, and Riccardo Santoni. "Hypofractionated stereotactic radiotherapy in combination with whole brain radiotherapy for brain metastases." Journal of Neuro-Oncology 91, no. 2 (2008): 207–12. http://dx.doi.org/10.1007/s11060-008-9700-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

RADES, DIRK, THEO VENINGA, STEFAN JANSSEN, and STEVEN E. SCHILD. "Outcomes After Whole-brain Radiotherapy for Brain Metastases with 5×4 Gy: Importance of Overall Treatment Time." Anticancer Research 36, no. 9 (2016): 4941–46. http://dx.doi.org/10.21873/anticanres.11060.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Khuntia, Deepak, Paul Brown, Jing Li, and Minesh P. Mehta. "Whole-Brain Radiotherapy in the Management of Brain Metastasis." Journal of Clinical Oncology 24, no. 8 (2006): 1295–304. http://dx.doi.org/10.1200/jco.2005.04.6185.

Full text

Abstract:

Brain metastases are an important cause of morbidity and mortality, afflicting nearly 170,000 Americans annually. The prognosis for these patients is poor, with median survival times measured in months. In this review article, we present the standard treatment approach of whole-brain radiotherapy and discuss new directions, including the role of chemical modifiers and the management and prevention of neurocognitive deficits.

APA, Harvard, Vancouver, ISO, and other styles

13

Brown, Paul D., Manmeet S. Ahluwalia, Osaama H. Khan, Anthony L. Asher, Jeffrey S. Wefel, and Vinai Gondi. "Whole-Brain Radiotherapy for Brain Metastases: Evolution or Revolution?" Journal of Clinical Oncology 36, no. 5 (2018): 483–91. http://dx.doi.org/10.1200/jco.2017.75.9589.

Full text

Abstract:

An estimated 20% of patients with cancer will develop brain metastases. Approximately 200,000 individuals in the United States alone receive whole-brain radiotherapy (WBRT) each year to treat brain metastases. Historically, the prognosis of patients with brain metastases has been poor; however, with new therapies, this is changing. Because patients are living longer following the diagnosis and treatment of brain metastases, there has been rising concern about treatment-related toxicities associated with WBRT, including neurocognitive toxicity. In addition, recent clinical trials have raised qu

APA, Harvard, Vancouver, ISO, and other styles

14

Grob, J. J., J. Regis, R. Laurans, et al. "Radiosurgery without whole brain radiotherapy in melanoma brain metastases." European Journal of Cancer 34, no. 8 (1998): 1187–92. http://dx.doi.org/10.1016/s0959-8049(98)00026-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Sneed, Penny K., Kathleen R. Lamborn, Julie M. Forstner, et al. "Radiosurgery for brain metastases: is whole brain radiotherapy necessary?" International Journal of Radiation Oncology*Biology*Physics 43, no. 3 (1999): 549–58. http://dx.doi.org/10.1016/s0360-3016(98)00447-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Kocher, Martin, Mohammad Maarouf, Mark Bendel, Juergen Voges, Rolf-Peter Müller, and Volker Sturm. "Linac Radiosurgery Versus Whole Brain Radiotherapy for Brain Metastases." Strahlentherapie und Onkologie 180, no. 5 (2004): 263–67. http://dx.doi.org/10.1007/s00066-004-1180-y.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Fleckenstein**, Katharina, Holger Hof**, Frank Lohr, Frederik Wenz, and Michael Wannenmacher. "Prognostic Factors for Brain Metastases after Whole Brain Radiotherapy." Strahlentherapie und Onkologie 180, no. 5 (2004): 268–73. http://dx.doi.org/10.1007/s00066-004-1234-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Okada, Yukinori, Mariko Kobayashi, Mio Shinozaki, et al. "Survival time and prognostic factors after whole-brain radiotherapy of brain metastases from of breast cancer." Acta Radiologica Open 9, no. 7 (2020): 205846012093874. http://dx.doi.org/10.1177/2058460120938744.

Full text

Abstract:

Background Breast cancer has a poor prognosis due to the high risk of distant metastasis. Purpose To identify the prognosticators of brain metastasis from breast cancer treated by whole-brain radiotherapy. Material and Methods We evaluated patients diagnosed with primary brain metastasis without carcinomatous meningitis from breast cancer and had undergone whole-brain radiotherapy as initial treatment between 1 January 2010 and 30 September 2019. We investigated associations between overall survival time from diagnosis using cranial contrast-enhanced magnetic resonance imaging (MRI)/computed t

APA, Harvard, Vancouver, ISO, and other styles

19

Ramadan, Islam, Shaaban El-Assal, Mohamed Farouk, Sherif El-zawawy, and Hany El-Deeb. "Comparative Study Evaluating Cognitive Functions in Patients Receiving Conventional Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy." Tumori Journal 107, no. 1_suppl (2021): 16. http://dx.doi.org/10.1177/03008916211016800.

Full text

Abstract:

Background: Whole brain radiotherapy is the treatment of choice for patients with brain metastases. However, neurocognitive functions decline due to impaired hippocampal neurogenesis might occur thereafter. It is hypothesized that conformal hippocampal avoidance during the course of WBRT might provide meaningful neurocognitive functions preservation. Our study aims to demonstrate the impact of delivering HA‑WBRT on NCF changes in patients receiving WBRT. Methods: fifty patients who were referred for cranial irradiation were enrolled in the study. Before the HA‑WBRT course and randomly assigned

APA, Harvard, Vancouver, ISO, and other styles

20

Dang Quoc, Soai, Quang Bui Vinh, Cuong Bui Xuan, Toan Hoang Van, and Truong Vu. "Analyzing Planning Techniques for Whole Brain Radiotherapy." International Journal of Medical Physics, Clinical Engineering and Radiation Oncology 09, no. 01 (2020): 1–13. http://dx.doi.org/10.4236/ijmpcero.2020.91001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Nieder, Carsten, Adelgunde Leicht, Babak Motaref, Ursula Nestle, Marcus Niewald, and Klaus Schnabel. "Late Radiation Toxicity After Whole-Brain Radiotherapy." American Journal of Clinical Oncology: Cancer Clinical Trials 22, no. 6 (1999): 573. http://dx.doi.org/10.1097/00000421-199912000-00007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Irfan, I., S. Kundan, and D. Ghosh. "PO-0652: Hippocampal avoidance whole brain radiotherapy." Radiotherapy and Oncology 111 (2014): S1. http://dx.doi.org/10.1016/s0167-8140(15)30770-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Ferreri, Andrés JM, Lisa DeAngelis, Gerald Illerhaus, et al. "Whole-brain radiotherapy in primary CNS lymphoma." Lancet Oncology 12, no. 2 (2011): 118–19. http://dx.doi.org/10.1016/s1470-2045(11)70018-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Kazda, Tomáš, Petr Pospíšil, Hana Doleželová, Radim Jančálek, and Pavel Šlampa. "Whole brain radiotherapy: Consequences for personalized medicine." Reports of Practical Oncology & Radiotherapy 18, no. 3 (2013): 133–38. http://dx.doi.org/10.1016/j.rpor.2013.03.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Mehta, Minesh P., Hidefumi Aoyama, and Vinai Gondi. "The Changing Role of Whole-Brain Radiotherapy." JAMA Oncology 3, no. 8 (2017): 1021. http://dx.doi.org/10.1001/jamaoncol.2016.5414.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

D’Agostino, Giuseppe Roberto, Rosa Autorino, Angelo Pompucci, et al. "Whole-Brain Radiotherapy Combined with Surgery or Stereotactic Radiotherapy in Patients with Brain Oligometastases." Strahlentherapie und Onkologie 187, no. 7 (2011): 421–25. http://dx.doi.org/10.1007/s00066-011-2228-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Duan, Lei, Rong Zeng, Ke-Hu Yang, et al. "Whole Brain Radiotherapy Combined with Stereotactic Radiotherapy Versus Stereotactic Radiotherapy Alone for Brain Metastases: a Meta-analysis." Asian Pacific Journal of Cancer Prevention 15, no. 2 (2014): 911–15. http://dx.doi.org/10.7314/apjcp.2014.15.2.911.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Li, L., M. Feng, P. Xu, et al. "Whole brain radiotherapy plus simultaneous in-field boost versus whole brain radiotherapy plus fractionated stereotactic radiotherapy for multiple brain metastases of non-small cell lung cancer." Annals of Oncology 30 (October 2019): v149. http://dx.doi.org/10.1093/annonc/mdz243.018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

la Fuente, Macarena de, Kathryn Beal, Richard Carvajal, and Thomas J. Kaley. "Whole-brain radiotherapy in patients with brain metastases from melanoma." CNS Oncology 3, no. 6 (2014): 401–6. http://dx.doi.org/10.2217/cns.14.40.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Nieder, Carsten. "Influence of Whole-Brain Radiotherapy on Remission of Brain Metastases." Journal of Clinical Oncology 24, no. 24 (2006): 4037. http://dx.doi.org/10.1200/jco.2005.05.1185.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Akiba, T., E. Kunieda, A. Kogawa, T. Komatsu, Y. Tamai, and Y. Ohizumi. "Re-irradiation for Metastatic Brain Tumors with Whole-brain Radiotherapy." Japanese Journal of Clinical Oncology 42, no. 4 (2012): 264–69. http://dx.doi.org/10.1093/jjco/hys007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Pechoux, Cécile Le, Frederic Dhermain, and Benjamin Besse. "Whole brain radiotherapy in patients with NSCLC and brain metastases." Lancet 388, no. 10055 (2016): 1960–62. http://dx.doi.org/10.1016/s0140-6736(16)31391-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Kondziolka, Douglas, Ajay Niranjan, John C. Flickinger, and L. Dade Lunsford. "Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases." American Journal of Clinical Oncology 28, no. 2 (2005): 173–79. http://dx.doi.org/10.1097/01.coc.0000143016.15783.5b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Vermeulen, Sandra S. "Whole brain radiotherapy in the treatment of metastatic brain tumors." Seminars in Surgical Oncology 14, no. 1 (1998): 64–69. http://dx.doi.org/10.1002/(sici)1098-2388(199801/02)14:1<64::aid-ssu8>3.0.co;2-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Lynch, Meghan. "Preservation of cognitive function following whole brain radiotherapy in patients with brain metastases: Complications, treatments, and the emerging role of memantine." Journal of Oncology Pharmacy Practice 25, no. 3 (2018): 657–62. http://dx.doi.org/10.1177/1078155218798176.

Full text

Abstract:

Whole brain radiotherapy is the mainstay of treatment for patients suffering from stage IV malignancies that have metastasized to the brain. Although this therapy is often effective at reducing tumor size and burden, it is associated with a spectrum of toxicities that often result in irreversible cognitive decline. Various drug and non-drug therapies have been evaluated to treat this neurotoxicity after whole brain radiotherapy is administered; however, currently available options have shown little benefit or come with side effects themselves that may outweigh the benefits of their use. For th

APA, Harvard, Vancouver, ISO, and other styles

36

Madden, Kathleen. "Identifying and Managing Complications of Whole Brain Radiotherapy." Clinical Journal of Oncology Nursing 13, no. 4 (2009): 446–48. http://dx.doi.org/10.1188/09.cjon.446-448.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

DeAngelis, L. M. "Whither whole brain radiotherapy for primary CNS lymphoma?" Neuro-Oncology 16, no. 8 (2014): 1032–34. http://dx.doi.org/10.1093/neuonc/nou122.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Wang, Shuo, Dandan Zheng, Chi Zhang, et al. "Automatic planning on hippocampal avoidance whole-brain radiotherapy." Medical Dosimetry 42, no. 1 (2017): 63–68. http://dx.doi.org/10.1016/j.meddos.2016.12.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Zhao, Ren, Wei Kong, Jun Shang, Hong Zhe, and Yan-Yang Wang. "Hippocampal-Sparing Whole-Brain Radiotherapy for Lung Cancer." Clinical Lung Cancer 18, no. 2 (2017): 127–31. http://dx.doi.org/10.1016/j.cllc.2016.09.007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Lutz, Stephen. "Palliative whole-brain radiotherapy fractionation: Convenience versus cognition?" Cancer 110, no. 11 (2007): 2363–65. http://dx.doi.org/10.1002/cncr.23069.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Kondziolka, Douglas, Atul Patel, L. Dade Lunsford, Amin Kassam, and John C. Flickinger. "Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases." International Journal of Radiation Oncology*Biology*Physics 45, no. 2 (1999): 427–34. http://dx.doi.org/10.1016/s0360-3016(99)00198-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Yuan, Xi, Wen-Jie Liu, Bing Li, Ze-Tian Shen, Jun-shu Shen, and Xi-Xu Zhu. "A Bayesian network meta-analysis of whole brain radiotherapy and stereotactic radiotherapy for brain metastasis." Medicine 96, no. 34 (2017): e7698. http://dx.doi.org/10.1097/md.0000000000007698.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Miura, Kosei, Hiromasa Kurosaki, Nobuko Utsumi, and Hideyuki Sakurai. "Use of a Head-Tilting Baseplate During Tomotherapy to Shorten the Irradiation Time and Protect the Hippocampus and Lens in Hippocampal Sparing-Whole Brain Radiotherapy." Technology in Cancer Research & Treatment 20 (January 1, 2021): 153303382098682. http://dx.doi.org/10.1177/1533033820986824.

Full text

Abstract:

Purpose: The aim of this study is to comparatively examine the possibility of reducing the exposure dose to organs at risk, such as the hippocampus and lens, and improving the dose distribution of the planned target volume with and without the use of a head-tilting base plate in hippocampal-sparing whole-brain radiotherapy using tomotherapy. Methods: Five paired images of planned head computed tomography without and with tilt were analyzed. The hippocampus and planning target volume were contoured according to the RTOG 0933 contouring atlas protocol. The hippocampal zone to be avoided was deli

APA, Harvard, Vancouver, ISO, and other styles

44

Kim, Michelle M., Hemant Parmar, Yue Cao, et al. "Concurrent whole brain radiotherapy and RRx-001 for melanoma brain metastases." Neuro-Oncology 18, no. 3 (2016): 455–56. http://dx.doi.org/10.1093/neuonc/nov317.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Hoffmann, Christian, Luitpold Distel, Stefan Knippen, et al. "Brain volume reduction after whole-brain radiotherapy: quantification and prognostic relevance." Neuro-Oncology 20, no. 2 (2017): 268–78. http://dx.doi.org/10.1093/neuonc/nox150.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Jiang, Cecilia, Jeffrey M. Switchenko, David H. Lawson, Melinda Lynne Yushak, and Mohammad Khurram Khan. "Institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases." Journal of Clinical Oncology 38, no. 15_suppl (2020): e14504-e14504. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e14504.

Full text

Abstract:

e14504 Background: The management of melanoma with multiple brain metastases (MBM) is complex given improvements in targeted agents, immunotherapy, and radiotherapy. Whole brain radiation therapy (WBRT) is a radiotherapy technique with limited outcomes data. We report our institutional outcomes for MBM patients receiving WBRT and assess whether certain clinical factors impact prognosis. Methods: A retrospective review of a single institution database was performed. Patients diagnosed with MBM from 2000-2018 treated with WBRT, with or without systemic treatments, were included. Post-WBRT brain

APA, Harvard, Vancouver, ISO, and other styles

47

Wygoda, M., I. Ospovat, A. Wygoda, N. Adika, and Y. Shoshan. "PO-0773 STEREOTACTIC RADIOSURGERY WITHOUT WHOLE BRAIN RADIOTHERAPY FOR BRAIN METASTASES." Radiotherapy and Oncology 103 (May 2012): S299. http://dx.doi.org/10.1016/s0167-8140(12)71106-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Fogarty, Gerald B., Angela Hong, and John F. Thompson. "Should patients with melanoma brain metastases receive adjuvant whole-brain radiotherapy?" Lancet Oncology 16, no. 5 (2015): e195-e196. http://dx.doi.org/10.1016/s1470-2045(15)70183-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Pulenzas, Natalie, Luluel Khan, May Tsao, et al. "Fatigue scores in patients with brain metastases receiving whole brain radiotherapy." Supportive Care in Cancer 22, no. 7 (2014): 1757–63. http://dx.doi.org/10.1007/s00520-014-2140-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Rades, Dirk, Jasmin N. Evers, Theo Veninga, Lukas J. A. Stalpers, Radka Lohynska, and Steven E. Schild. "Shorter-Course Whole-Brain Radiotherapy for Brain Metastases in Elderly Patients." International Journal of Radiation Oncology*Biology*Physics 81, no. 4 (2011): e469-e473. http://dx.doi.org/10.1016/j.ijrobp.2011.01.058.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!